Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain

Nature Medicine

Volumn 22, Issue 12, 2016, Pages 1465-1469

  Raymond, Donald D ^a   Stewart, Shaun M ^b,j   Lee, Jiwon ^c   Ferdman, Jack ^b   Bajic, Goran ^a   Do, Khoi T ^a   Ernandes, Michael J ^a,d   Suphaphiphat, Pirada ^b   Settembre, Ethan C ^b   Dormitzer, Philip R ^b,j,k   Del Giudice, Giuseppe ^e,j,l   Finco, Oretta ^e,j,l   Kang, Tae Hyun ^c   Ippolito, Gregory C ^f   Georgiou, George ^c,f   Kepler, Thomas B ^g   Haynes, Barton F ^h   Moody, M Anthony ^h   Liao, Hua Xin ^h   Schmidt, Aaron G ^a   Harrison, Stephen C ^a,i   more..

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Seqirus Pharmaceuticals Inc   (United States)

^c The University of Texas at Austin   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^f UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^j GSK Vaccines ^*  (United States)

^k Vaccine Research East and Early Development   (United States)

^l GSK   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CARBOXYLIC ACID; GLUTAMIC ACID; GLUTAMINE; GUANIDINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; SIALIC ACID; VIRUS ANTIBODY; SIALIC ACID DERIVATIVE;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; BINDING SITE; EGG; HEMAGGLUTINATION INHIBITION; HUMAN; HUMAN CELL; HYDROGEN BOND; INFLUENZA A VIRUS (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS; NONHUMAN; PANDEMIC INFLUENZA; PHYLOGENETIC TREE; PRIORITY JOURNAL; RECEPTOR BINDING SITE; SEASONAL INFLUENZA; SOMATIC HYPERMUTATION; VIRUS STRAIN; WILD TYPE; ANIMAL; AVIAN INFLUENZA; CHICKEN; CRYSTALLIZATION; DOG; IMMUNOLOGY; INFLUENZA, HUMAN; MDCK CELL LINE; PLASMA CELL; PROTEIN TERTIARY STRUCTURE; VACCINE IMMUNOGENICITY; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHICKENS; CRYSTALLIZATION; DOGS; EGGS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOGENICITY, VACCINE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MADIN DARBY CANINE KIDNEY CELLS; PLASMA CELLS; PROTEIN STRUCTURE, TERTIARY; SIALIC ACIDS;

EID: 84994674021     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4223     Document Type: Article

References (37)

1. Wu, X. et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329, 856-861 (2010).
2. Wu, X. et al. Maturation and diversity of the VRC01 antibody lineage over 15 years of chronic HIV-1 infection. Cell 161, 470-485 (2015).
3. Zhou, T. et al. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329, 811-817 (2010).
4. Ekiert, D. C. et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489, 526-532 (2012).
5. Hong, M. et al. Antibody recognition of the pandemic H1N1 influenza virus hemagglutinin receptor-binding site. J. Virol. 87, 12471-12480 (2013).
6. Schmidt, A. G. et al. immunogenic stimulus for germline precursors of antibodies that engage the influenza hemagglutinin receptor-binding site. Cell Rep. 13, 2842-2850 (2015).
7. Schmidt, A. G. et al. Viral receptor-binding site antibodies with diverse germline origins. Cell 161, 1026-1034 (2015).
8. Whittle, J. R. et al. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 108, 14216-14221 (2011).
9. Skehel, J. J., Wiley, D. C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531-569 (2000).
10. Rogers, G. N., Paulson, J. C. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127, 361-373 (1983).
11. Ha, Y., Stevens, D. J., Skehel, J. J., Wiley, D. C. X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. Virology 309, 209-218 (2003).
12. Shinya, K. et al. Avian flu: influenza virus receptors in the human airway. Nature 440, 435-436 (2006).
13. Robertson, J. S. et al. Structural changes in the hemagglutinin which accompany egg adaptation of an influenza A (H1N1) virus. Virology 160, 31-37 (1987).
14. Ito, T. et al. Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J. Virol. 71, 3357-3362 (1997).
15. Xu, Q., Wang, W., Cheng, X., Zengel, J., Jin, H. Influenza H1N1 A/Solomon Island/3/06 virus receptor-binding specificity correlates with virus pathogenicity, antigenicity and immunogenicity in ferrets. J. Virol. 84, 4936-4945 (2010).
16. Faenzi, E. et al. One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies. Vaccine 30, 4086-4094 (2012).
17. Moody, M. A. et al. H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. PLoS One 6, e25797 (2011).
18. Kepler, T. B. et al. Reconstructing a B cell clonal lineage. II. Mutation, selection and affinity maturation. Front. Immunol. 5, 170 (2014).
19. Kepler, T. B. Reconstructing a B cell clonal lineage. I. Statistical inference of unobserved ancestors. F1000Res. 2, 103 (2013).
20. Weis, W. et al. Structure of the influenza virus hemagglutinin complexed with its receptor, sialic acid. Nature 333, 426-431 (1988).
21. Jackson, K. J. et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe 16, 105-114 (2014).
22. Tan, Y. C. et al. High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination. Clin. Immunol. 151, 55-65 (2014).
23. Wrammert, J. et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181-193 (2011).
24. Scholtissek, C., von Hoyningen, V., Rott, R. Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology 89, 613-617 (1978).
25. Nakajima, K., Desselberger, U., Palese, P. Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature 274, 334-339 (1978).
26. Kozlov, J. V. et al. On the origin of the H1N1 (A/USSR/90/77) influenza virus. J. Gen. Virol. 56, 437-440 (1981).
27. Lee, J. et al. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nat. Med. http://dx. doi. org/10. 1038/nm. 4224 (2016).
28. Liao, H. X. et al. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J. Virol. Methods 158, 171-179 (2009).
29. Moody, M. A. et al. HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages. J. Virol. 86, 7496-7507 (2012).
30. Lavinder, J. J. et al. Identification and characterization of the constituent human serum antibodies elicited by vaccination. Proc. Natl. Acad. Sci. USA 111, 2259-2264 (2014).
31. DeKosky, B. J. et al. In-depth determination and analysis of the human paired heavy-and light-chain antibody repertoire. Nat. Med. 21, 86-91 (2015).
32. Schmidt, A. G. et al. Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc. Natl. Acad. Sci. USA 110, 264-269 (2013).
33. World Health Organization Global Influenza Surveillance Network. Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza (World Health Organization Press, Geneva, Switzerland, 2011).
34. Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125-132 (2010).
35. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
36. Cowtan, K., Main, P. Miscellaneous algorithms for density modification. Acta Crystallogr. D Biol. Crystallogr. 54, 487-493 (1998).
37. Jones, T. A., Zou, J. Y., Cowan, S. W., Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).